TrialBlood2021

Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.

Debra D Pittman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.